speb/financial-data huggingface dataset:
CLS.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 130300000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 45800000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Change In Inventory: -27700000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 3000000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Change In Payable: 45800000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 45800000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Change In Receivables: -66900000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -45800000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -66900000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -120300000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 1628700000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 1556800000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -77700000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 2374700000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 1531900000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 4376500000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Current Debt: 26700000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 26700000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 3054200000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -100000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Deferred Tax: -100000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 37400000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 11100000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 37400000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 11100000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 116900000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.74
CLS.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 86200000.00
CLS.TO income_statement (quarterly, 2025-03-31) — EBIT: 127400000.00
CLS.TO income_statement (quarterly, 2025-03-31) — EBITDA: 164800000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 85300000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 303000000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -213900000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Finished Goods: 137100000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 93600000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 20400000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -1300000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -15700000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Goodwill: 340500000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 638000000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 2154300000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 661100000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Gross Profit: 273900000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 5600000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 117800000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Interest Expense: 13700000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 13700000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 14800000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Inventory: 1788300000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 2498500000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -36700000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 310000000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 915000000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 915000000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 310000000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -167000000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -77700000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Net Debt: 638700000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Net Income: 86200000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 86200000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 86200000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 86200000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 86200000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 86200000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 86200000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: -13700000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 143000000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 143000000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -13700000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -57600000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 661100000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -36700000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 918800000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 86900000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 49100000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 86900000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 49100000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 85300000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 170000000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Normalized Income: 90142304.31
CLS.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 130300000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 20400000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Operating Income: 132700000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 2648600000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 115600000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 149300000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -15700000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: -5300000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 297500000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 6200000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 72400000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 174500000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -100000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Other Properties: 661100000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Payables: 1495600000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 3027500000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Pretax Income: 113700000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: -221600000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -36700000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Raw Materials: 1537600000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 2135900000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 2348400000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 37400000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -167000000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -77700000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Research And Development: 17600000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 3900000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -337600000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 112500000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 115600000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Special Income Charges: -3900000.00
CLS.TO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 26000000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 1556800000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 918800000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -1257695.69
CLS.TO income_statement (quarterly, 2025-03-31) — Tax Provision: 27500000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.24
CLS.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 5834900000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 2471800000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Total Debt: 941700000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 1556800000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 2515900000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 4278100000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 1458400000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1223900000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 128800000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 117800000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items: -5200000.00
CLS.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -5200000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 205600000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Work In Process: 113600000.00
CLS.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: 1322300000.00
CLS.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 84000000.00
CLS.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 2893400000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1595200000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 2287800000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 466100000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -22800000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Amortization: 11100000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Amortization Of Intangibles Income Statement: 11100000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 115100000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Basic EPS: 1.83
CLS.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 303000000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -32500000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1621500000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 313800000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 313800000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -106600000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -35000000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 152400000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 270400000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Change In Inventory: -129800000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -9400000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Change In Payable: 270400000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 270400000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Change In Receivables: -151900000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -20700000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -151900000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: 10800000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 1621500000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 1757900000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 300000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -40000000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2522400000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 1575700000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 4771000000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Current Debt: 26600000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 26600000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 3320800000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -14900000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Deferred Tax: -14900000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 45300000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 11100000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 45300000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 11100000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 115900000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.82
CLS.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 211000000.00
CLS.TO income_statement (quarterly, 2025-06-30) — EBIT: 270800000.00
CLS.TO income_statement (quarterly, 2025-06-30) — EBITDA: 316100000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 90800000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 313800000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -106600000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Finished Goods: 292900000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 119900000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -96100000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -1300000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -900000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Goodwill: 340800000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 627600000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 2310600000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 672900000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Gross Profit: 371000000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 50600000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 123300000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Interest Expense: 13500000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 13500000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 12500000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Inventory: 1918100000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 2633100000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -35000000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 300000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 190000000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 848600000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 848600000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 190000000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -256900000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -39700000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Net Debt: 561400000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Net Income: 211000000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 211000000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 211000000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 211000000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 211000000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 211000000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 211000000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: -13500000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -66900000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -66900000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -13500000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -2500000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 672900000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -32500000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 1130300000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 95200000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 42900000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 95200000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 42900000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 90800000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 331900000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Normalized Income: 223956000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 152400000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -96100000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Operating Income: 287000000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 2893400000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 114991980.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 251300000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 26600000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -900000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: -16200000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 286800000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 12600000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 74400000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 180100000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -400000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Other Properties: 672900000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Payables: 1718500000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 3294200000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Pretax Income: 257300000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Business: 0.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -32500000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Raw Materials: 1492500000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 2287800000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2488200000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 45300000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -256900000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -40000000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Research And Development: 34000000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 14500000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -126600000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 38900000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 114991980.00
CLS.TO income_statement (quarterly, 2025-06-30) — Special Income Charges: -14500000.00
CLS.TO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 15200000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 1757900000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 1130300000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -2844000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Tax Provision: 46300000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.18
CLS.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 6241100000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 2606500000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 875200000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 1757900000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 2606400000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 4483200000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 1470100000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 1162400000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 272500000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 123300000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items: -15800000.00
CLS.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -15800000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 202200000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Work In Process: 132700000.00
CLS.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: 1450200000.00
CLS.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 86200000.00
CLS.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 3194000000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 1679800000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 2439300000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 480300000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -29500000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Amortization: 11400000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Amortization Of Intangibles Income Statement: 11400000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 313800000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -37300000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 1621600000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 305900000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 305900000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -96800000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -37300000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 126200000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 188600000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Change In Inventory: -128600000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -900000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Change In Payable: 188600000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 188600000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Change In Receivables: -151500000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -92400000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -151500000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: -7900000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 1621600000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 2028600000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
CLS.TO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 2777900000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 1673200000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 5142800000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Current Debt: 27400000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 27400000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 3502300000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -1100000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Deferred Tax: -1100000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 40300000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 11400000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 40300000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 11400000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 267800000.00
CLS.TO income_statement (quarterly, 2025-09-30) — EBIT: 323700000.00
CLS.TO income_statement (quarterly, 2025-09-30) — EBITDA: 364000000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 94100000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 305900000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -96800000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Finished Goods: 274400000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 88900000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -112200000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Ppe: -700000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -1100000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -13500000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Goodwill: 340700000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 616100000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 2468800000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 676400000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Gross Profit: 416100000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 45700000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 121900000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Interest Expense: 12800000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 12800000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 13400000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Inventory: 2046700000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 2812700000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -37300000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 756700000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 756700000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -96800000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Net Debt: 478200000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Net Income: 267800000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 267800000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 267800000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 267800000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 267800000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 267800000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 267800000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: -12800000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -96800000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -96800000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -12800000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 676400000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -37300000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 1412500000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 99500000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 45100000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 99500000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 45100000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 94100000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 370000000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Normalized Income: 272960000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 126200000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -112200000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Operating Income: 329900000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 3194000000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 115032686.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 350900000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -13500000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Other Income Expense: -6200000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 275400000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 8200000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 71900000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 179900000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -200000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Other Properties: 676400000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Payables: 1801700000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 3474900000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Pretax Income: 310900000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Business: 0.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -37300000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Raw Materials: 1617600000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 2439300000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 2749000000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 40300000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -96800000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
CLS.TO income_statement (quarterly, 2025-09-30) — Research And Development: 36400000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 4200000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 141200000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 38400000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 115032686.00
CLS.TO income_statement (quarterly, 2025-09-30) — Special Income Charges: -4900000.00
CLS.TO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 15600000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 2028600000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 1412500000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -840000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Tax Provision: 43100000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.14
CLS.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 6606700000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 2785300000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Total Debt: 784100000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 2028600000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 2864100000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 4578100000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 1463900000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 1075800000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 325000000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 121900000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items: -6000000.00
CLS.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -6000000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 201000000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Work In Process: 154700000.00
CLS.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: 1640500000.00
CLS.TO income_statement (annual, 2025-12-31) — +Operating Expense: 423700000.00
CLS.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 112300000.00
CLS.TO income_statement (annual, 2025-12-31) — +Total Revenue: 12390900000.00
CLS.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 3654900000.00
CLS.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 1866100000.00
CLS.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1866100000.00
CLS.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 2638100000.00
CLS.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 2638100000.00
CLS.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -1044700000.00
CLS.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -1044700000.00
CLS.TO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 343300000.00
CLS.TO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 343300000.00
CLS.TO balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -30500000.00
CLS.TO balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -30500000.00
CLS.TO income_statement (annual, 2025-12-31) — Amortization: 45600000.00
CLS.TO income_statement (quarterly, 2025-12-31) — Amortization: 12000000.00
CLS.TO income_statement (annual, 2025-12-31) — Amortization Of Intangibles Income Statement: 45600000.00
CLS.TO income_statement (quarterly, 2025-12-31) — Amortization Of Intangibles Income Statement: 12000000.00
CLS.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 115300000.00
CLS.TO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 115000000.00
CLS.TO income_statement (annual, 2025-12-31) — Basic EPS: 7.22
CLS.TO income_statement (quarterly, 2025-12-31) — Basic EPS: 2.33
CLS.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 423300000.00
CLS.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 305900000.00
CLS.TO balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 543800000.00
CLS.TO balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 543800000.00
CLS.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -201200000.00
CLS.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -94700000.00
CLS.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 1619800000.00
CLS.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1619800000.00
CLS.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 595600000.00
CLS.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 595600000.00
CLS.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 595600000.00
CLS.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 595600000.00
CLS.TO balance_sheet (annual, 2025-12-31) — Cash Equivalents: 21400000.00
CLS.TO balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 21400000.00
CLS.TO balance_sheet (annual, 2025-12-31) — Cash Financial: 574200000.00
CLS.TO balance_sheet (quarterly, 2025-12-31) — Cash Financial: 574200000.00
CLS.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -283500000.00
CLS.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 133800000.00
CLS.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -203700000.00
CLS.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -94700000.00
CLS.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 659500000.00
CLS.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 250600000.00
CLS.TO cash_flow (annual, 2025-12-31) — Change In Account Payable: 909500000.00
CLS.TO cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 404700000.00
CLS.TO cash_flow (annual, 2025-12-31) — Change In Inventory: -427400000.00
CLS.TO cash_flow (quarterly, 2025-12-31) — Change In Inventory: -141300000.00
CLS.TO cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -25100000.00
CLS.TO cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -17800000.00
CLS.TO cash_flow (annual, 2025-12-31) — Change In Payable: 909500000.00
CLS.TO cash_flow (quarterly, 2025-12-31) — Change In Payable: 404700000.00
CLS.TO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 909500000.00
CLS.TO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 404700000.00
CLS.TO cash_flow (annual, 2025-12-31) — Change In Receivables: -569100000.00
CLS.TO cash_flow (quarterly, 2025-12-31) — Change In Receivables: -198800000.00
CLS.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: -112100000.00
CLS.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 46800000.00
CLS.TO cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -569100000.00
CLS.TO cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -198800000.00
CLS.TO cash_flow (annual, 2025-12-31) — Changes In Cash: 172300000.00
CLS.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: 289700000.00
CLS.TO balance_sheet (annual, 2025-12-31) — Common Stock: 1619800000.00
CLS.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 1619800000.00
CLS.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 2216300000.00
CLS.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 2216300000.00
CLS.TO cash_flow (annual, 2025-12-31) — Common Stock Issuance: 300000.00
CLS.TO cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
CLS.TO cash_flow (annual, 2025-12-31) — Common Stock Payments: -153400000.00
CLS.TO cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -35700000.00
CLS.TO income_statement (annual, 2025-12-31) — Cost Of Revenue: 10896800000.00
CLS.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 3221800000.00
CLS.TO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 293400000.00
CLS.TO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 293400000.00
CLS.TO balance_sheet (annual, 2025-12-31) — Current Assets: 5673200000.00
CLS.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 5673200000.00
CLS.TO balance_sheet (annual, 2025-12-31) — Current Debt: 26000000.00
CLS.TO balance_sheet (quarterly, 2025-12-31) — Current Debt: 26000000.00
CLS.TO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 26000000.00
CLS.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 26000000.00
CLS.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 3939600000.00
CLS.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 3939600000.00
CLS.TO balance_sheet (annual, 2025-12-31) — Current Provisions: 32900000.00
CLS.TO balance_sheet (quarterly, 2025-12-31) — Current Provisions: 32900000.00
CLS.TO cash_flow (annual, 2025-12-31) — Deferred Income Tax: -68400000.00
CLS.TO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -52300000.00
CLS.TO cash_flow (annual, 2025-12-31) — Deferred Tax: -68400000.00
CLS.TO cash_flow (quarterly, 2025-12-31) — Deferred Tax: -52300000.00
CLS.TO balance_sheet (annual, 2025-12-31) — Defined Pension Benefit: 9700000.00
CLS.TO balance_sheet (quarterly, 2025-12-31) — Defined Pension Benefit: 9700000.00
CLS.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 175700000.00
CLS.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 52700000.00
CLS.TO income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 45600000.00
CLS.TO income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 12000000.00
CLS.TO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 175700000.00
CLS.TO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 52700000.00
CLS.TO income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 45600000.00
CLS.TO income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 12000000.00
CLS.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 116200000.00
CLS.TO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 115900000.00
CLS.TO income_statement (annual, 2025-12-31) — Diluted EPS: 7.16
CLS.TO income_statement (quarterly, 2025-12-31) — Diluted EPS: 2.31
CLS.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 832500000.00
CLS.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 267500000.00
CLS.TO income_statement (annual, 2025-12-31) — EBIT: 1035800000.00
CLS.TO income_statement (quarterly, 2025-12-31) — EBIT: 313900000.00
CLS.TO income_statement (annual, 2025-12-31) — EBITDA: 1211500000.00
CLS.TO income_statement (quarterly, 2025-12-31) — EBITDA: 366600000.00
CLS.TO balance_sheet (annual, 2025-12-31) — Employee Benefits: 89500000.00
CLS.TO balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 89500000.00
CLS.TO cash_flow (annual, 2025-12-31) — End Cash Position: 595600000.00
CLS.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 595600000.00
CLS.TO balance_sheet (annual, 2025-12-31) — Financial Assets: 400000.00
CLS.TO balance_sheet (quarterly, 2025-12-31) — Financial Assets: 400000.00
CLS.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: -283500000.00
CLS.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 133800000.00
CLS.TO balance_sheet (annual, 2025-12-31) — Finished Goods: 260300000.00
CLS.TO balance_sheet (quarterly, 2025-12-31) — Finished Goods: 260300000.00
CLS.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: 458300000.00
CLS.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 155900000.00
CLS.TO cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -248300000.00
CLS.TO cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -60400000.00
CLS.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: -2500000.00
CLS.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: -700000.00
CLS.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -4700000.00
CLS.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -1000000.00
CLS.TO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -1700000.00
CLS.TO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -1700000.00
CLS.TO balance_sheet (annual, 2025-12-31) — Goodwill: 333100000.00
CLS.TO balance_sheet (quarterly, 2025-12-31) — Goodwill: 333100000.00
CLS.TO balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 605500000.00
CLS.TO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 605500000.00
CLS.TO balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 2668600000.00
CLS.TO balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 2668600000.00
CLS.TO balance_sheet (annual, 2025-12-31) — Gross PPE: 1754800000.00
CLS.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 1754800000.00
CLS.TO income_statement (annual, 2025-12-31) — Gross Profit: 1494100000.00
CLS.TO income_statement (quarterly, 2025-12-31) — Gross Profit: 433100000.00
CLS.TO cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 174800000.00
CLS.TO cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 72900000.00
CLS.TO balance_sheet (annual, 2025-12-31) — Income Tax Payable: 150700000.00
CLS.TO balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 150700000.00